PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer

Status unconfirmed

Conditions studied: Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma (PDAC)

In brief

Conduct a prospective study to assess the accuracy of a pancreatic cancer risk prediction model.

Key facts

Study ID

NCT04883450

Run by

Kaiser Permanente

People needed

126

Starts

2021-02-01

Expected to finish

2025-06-30

Last updated by the study team

2024-01-16

Who can join

Age: 50 and older, up to 84. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient must have 6 months of membership
• Patient has a measure for weight, Hemoglobin A1C, and Alanine transaminase (ALT) within the past 6 months
• Patient must have an increased predicted 18-month risk of pancreatic cancer based on the PRO-TECT model
• Speaks English or Spanish

You may not qualify if…

• Previous or current history of pancreatic cancer
• Metastatic cancer
• Current active cancer or undergoing chemotherapy for cancer
• Currently pregnant or breastfeeding
• Class IV heart failure
• Cirrhosis with ascites and/or varices
• Currently in a skilled nursing facility or under hospice care
• Has metal parts or implanted devices in the body, such as a pacemaker, defibrillator, or shrapnel
• End stage renal disease
• Cognitive impairment such that the person is unable to provide informed consent

Where it is running

• Kaiser Permanente Southern California — Pasadena, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.